Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 1 · 100%

Progression‐free survival (PSF) · people with advanced gastric cancer

Docetaxel leads to lower progression‐free survival ‐ Additive comparison compared with non‐docetaxel‐containing regimens (high certainty).

1 finding from 1 review

Chemotherapy for advanced gastric cancer 2017 · Cochrane Headline outcomes only
HR 0.7 [0.61, 0.81]
3 studies · 1323 participants
High